![glp-1 gilead Oral Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies[v1] Gilead continues M&A surge with](https://www.preprints.org/frontend/picture/ms_xml/manuscript/7be468775bea75bf2036c55c34b8f0dc/preprints-159314-g002.png)
glp-1 gilead Oral Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies[v1] Gilead continues M&A surge with
USD20.58
USD68.58
Pay in 4 interest-free payments of $5.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
![glp-1 gilead Oral Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies[v1] Gilead continues M&A surge with](https://imgproxy.divecdn.com/skkaWlFhTDPMbfIXmqOuyBKuimuCXFjfagjcvWa7beA/g:nowe:0:0/c:5076:2867/rs:fill:1200:675:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjIxODc5NzA5X2s2czFWcGkuanBn.webp)
![glp-1 gilead Oral Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies[v1] Gilead continues M&A surge with](https://www.frontiersin.org/files/Articles/1610368/xml-images/fimmu-16-1610368-g001.webp)
![glp-1 gilead Oral Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies[v1] Gilead continues M&A surge with](https://www.reuters.com/resizer/v2/A5LMRIAIC5NSBPOZC2N6I4NJ64.jpg?auth=7bba04e31e6a2f504d03a199f8dbde8ac292e9e28433c9a28636a6ed04af1f31&width=1920&quality=80)
![glp-1 gilead Oral Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies[v1] Gilead continues M&A surge with](https://www.safemedicines.org/wp-content/uploads/2025/05/McCall-GLP1-figure2.png)
